ES2072395T3 - Uso de interleuquina-4 para aumentar el numero de neutrofilos y para tratar la leucemia mieloide y monocitoide. - Google Patents

Uso de interleuquina-4 para aumentar el numero de neutrofilos y para tratar la leucemia mieloide y monocitoide.

Info

Publication number
ES2072395T3
ES2072395T3 ES90308198T ES90308198T ES2072395T3 ES 2072395 T3 ES2072395 T3 ES 2072395T3 ES 90308198 T ES90308198 T ES 90308198T ES 90308198 T ES90308198 T ES 90308198T ES 2072395 T3 ES2072395 T3 ES 2072395T3
Authority
ES
Spain
Prior art keywords
neutrophils
increase
monocitoid
interleukin
leukemia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90308198T
Other languages
English (en)
Inventor
Eric Bonnem
Lee Sullivan
Michael Grace
Loretta Bober
John Chu-Tay Tang
David Naveh
T L Nagabhushan
Jay Raman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Application granted granted Critical
Publication of ES2072395T3 publication Critical patent/ES2072395T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5406—IL-4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacture Of Macromolecular Shaped Articles (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Manufacture Of Alloys Or Alloy Compounds (AREA)

Abstract

Uso de IL-4 en la fabricación de una composición farmacéutica para aumentar el número de neutrófilos en un mamífero.
ES90308198T 1989-07-28 1990-07-26 Uso de interleuquina-4 para aumentar el numero de neutrofilos y para tratar la leucemia mieloide y monocitoide. Expired - Lifetime ES2072395T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38693789A 1989-07-28 1989-07-28

Publications (1)

Publication Number Publication Date
ES2072395T3 true ES2072395T3 (es) 1995-07-16

Family

ID=23527716

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90308198T Expired - Lifetime ES2072395T3 (es) 1989-07-28 1990-07-26 Uso de interleuquina-4 para aumentar el numero de neutrofilos y para tratar la leucemia mieloide y monocitoide.
ES94105833T Expired - Lifetime ES2089875T3 (es) 1989-07-28 1990-07-26 Metodo para purificar interleuquina-4.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES94105833T Expired - Lifetime ES2089875T3 (es) 1989-07-28 1990-07-26 Metodo para purificar interleuquina-4.

Country Status (20)

Country Link
EP (3) EP0484380A1 (es)
JP (2) JP2580391B2 (es)
KR (1) KR100191223B1 (es)
AT (2) ATE119395T1 (es)
AU (2) AU645514B2 (es)
CA (1) CA2064753A1 (es)
DE (2) DE69025961T2 (es)
DK (2) DK0410750T3 (es)
ES (2) ES2072395T3 (es)
FI (2) FI981585L (es)
GR (1) GR3019707T3 (es)
HK (1) HK185196A (es)
HU (1) HU215257B (es)
IL (2) IL95201A0 (es)
NO (1) NO304555B1 (es)
OA (1) OA09649A (es)
RU (1) RU2082756C1 (es)
SG (1) SG44544A1 (es)
WO (1) WO1991001744A2 (es)
ZA (1) ZA905896B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5723119A (en) * 1989-07-28 1998-03-03 Schering Corporation Method for enhancing wound healing/repair with IL-4
US5077388A (en) * 1990-05-31 1991-12-31 Schering Corporation Purification of human interleukin-4 from a secreted escherichia coli mutant
US5827670A (en) * 1990-08-02 1998-10-27 Fred Hutchinson Cancer Research Center Methods of isolating and detecting bone marrow stromal cells with VCAM-1-specific antibodies
US7449186B1 (en) 1990-08-02 2008-11-11 Fred Hutchinson Cancer Research Center Methods of blocking the interaction between stromal cells and hemopoietic cells with anti-VCAM-1 antibodies
AU660942B2 (en) * 1990-09-13 1995-07-13 Commonwealth Scientific And Industrial Research Organisation Ovine cytokine genes
JPH0747545B2 (ja) * 1991-01-10 1995-05-24 シェリング・コーポレーション 創傷治癒及び修復の修復段階を促進し、かつ感染した創傷及び糖尿病哺乳類の創傷の治癒を促進するためのｉｌ−４の用途
JPH07165602A (ja) * 1993-12-16 1995-06-27 Kirin Brewery Co Ltd 放射線障害防護剤
US5716612A (en) * 1994-09-07 1998-02-10 Schering Corporation Use of IL-4 for potentiation of chemotherapeutic agents
US6132737A (en) * 1997-09-29 2000-10-17 Revlon Consumer Products Corporation Method for reducing sunburn cell formation with cosmetic compositions containing ascorbic acid
ES2543819T3 (es) * 1998-11-09 2015-08-24 Biogen Inc. Tratamiento de neoplasias hematológicas asociadas con células tumorales circulantes utilizando anticuerpo quimérico dirigido contra CD20
WO2010123798A2 (en) 2009-04-20 2010-10-28 Galenbio, Inc. Compositions for transfection of biomolecules into cells
JP5784416B2 (ja) * 2011-08-26 2015-09-24 出光興産株式会社 菌類の回収方法
EP3995196B1 (en) * 2020-11-04 2023-08-09 Sartorius BIA Separations d.o.o. Purification process for lipid-membrane-enclosed complex assemblages

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4723000A (en) * 1983-07-05 1988-02-02 Biospectrum, Inc. Human interferon gamma and interleukin-2
SE8701004D0 (sv) * 1987-03-11 1987-03-11 Astra Ab Method for therapy of leukemias and certain other malignancies
US5077388A (en) * 1990-05-31 1991-12-31 Schering Corporation Purification of human interleukin-4 from a secreted escherichia coli mutant
ZA912037B (en) * 1990-03-21 1992-03-25 Schering Corp Use of il-4 to enhance immune response to infectious antigenic challenges

Also Published As

Publication number Publication date
EP0410750A2 (en) 1991-01-30
WO1991001744A3 (en) 1991-04-04
EP0410750B1 (en) 1995-03-08
JPH0940575A (ja) 1997-02-10
EP0618220A1 (en) 1994-10-05
DE69017547D1 (de) 1995-04-13
FI102039B1 (fi) 1998-10-15
FI981585A0 (fi) 1990-07-26
JP2580391B2 (ja) 1997-02-12
JPH04506299A (ja) 1992-11-05
KR100191223B1 (ko) 1999-06-15
FI981585A7 (fi) 1998-07-10
AU6055890A (en) 1991-03-11
FI981585L (fi) 1998-07-10
HK185196A (en) 1996-10-11
ATE135366T1 (de) 1996-03-15
WO1991001744A2 (en) 1991-02-21
FI102039B (fi) 1998-10-15
AU645514B2 (en) 1994-01-20
FI920367A0 (fi) 1992-01-28
GR3019707T3 (en) 1996-07-31
DE69017547T2 (de) 1995-11-02
AU5476194A (en) 1994-06-02
NO920351D0 (no) 1992-01-27
IL95201A0 (en) 1991-06-10
AU661221B2 (en) 1995-07-13
HU9200254D0 (en) 1992-04-28
DE69025961T2 (de) 1996-10-31
HU215257B (hu) 1998-11-30
EP0618220B1 (en) 1996-03-13
DE69025961D1 (de) 1996-04-18
DK0410750T3 (da) 1995-07-10
NO920351L (no) 1992-03-27
DK0618220T3 (da) 1996-07-22
NO304555B1 (no) 1999-01-11
ES2089875T3 (es) 1996-10-01
KR920700670A (ko) 1992-08-10
ATE119395T1 (de) 1995-03-15
CA2064753A1 (en) 1991-01-29
ZA905896B (en) 1991-04-24
IL121897A0 (en) 1998-03-10
OA09649A (en) 1993-05-15
EP0410750A3 (en) 1991-06-19
RU2082756C1 (ru) 1997-06-27
HUT60146A (en) 1992-08-28
SG44544A1 (en) 1997-12-19
EP0484380A1 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
SU701553A3 (ru) Многослойный материал
ES2072395T3 (es) Uso de interleuquina-4 para aumentar el numero de neutrofilos y para tratar la leucemia mieloide y monocitoide.
MX9100662A (es) Material laminado y procedimiento para fabricar el mismo
DK68789A (da) Injektionspen
TR18901A (tr) Benzoilureido-nitro-difenil eterler imallerine mahsus usuller ve insektisid olarak kullanilmalari
DK49488A (da) Anaestesi-praeparat
IT1178516B (it) Miscela effervescente, in particolare per pastiglie effervescenti, pastiglie effervescenti prodotte con uso della stessa e procedimento per la loro fabbricazione
DK404889D0 (da) Nye antiarrytmiske midler ii
FI905791A7 (fi) Kaasun suihkutin
IT1130485B (it) Perfezionamento nella produzione della metacroleina
IT1083189B (it) Luminofori emettenti nell'ultra-violetto
DE3856144D1 (de) Durch Prägen formbares Material
BR8905701A (pt) Ornamentos pessoais
FR2566662B1 (fr) Association medicamenteuse utilisee en photochimiotherapie
IT1114003B (it) Procedimento per ottenere,da tronchi anche di piccole dimensioni,e con il minimo sfrido,fogli sottili di legno,presentanti tutti un effetto decorativo ottimo
BR8103907A (pt) Mistura fisica curavel e artigo resultante
DE69022606D1 (de) Menschlichen Monozyt-Makrophagen-Koloniestimulierungsfaktor enthaltende Zusammensetzung.
FR2610867B1 (fr) Materiau composite transparent
ATA234488A (de) Gasduese
DK692087A (da) Peptid med renin-inhibitorisk virkning
SU566555A1 (ru) Стол
IT1091050B (it) Composizione e procedimento per la fabbricazione di mattonelle o piastrelle aventi l'aspetto del marmo
DK0484331T3 (da) Enkeltkrystaller af -g(b)-phenylpropiophenoner
KR900015227U (ko) 함실이 형성된 버클
IT8015248U1 (it) Interruttore perfezionato particolarmente adatto ad essere impiegato per l'azionamento di lampade da tavolo e simili

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 410750

Country of ref document: ES